Advertisement
Singapore markets closed
  • Straits Times Index

    3,322.08
    -8.69 (-0.26%)
     
  • S&P 500

    5,346.99
    -5.97 (-0.11%)
     
  • Dow

    38,798.99
    -87.21 (-0.22%)
     
  • Nasdaq

    17,133.12
    -39.97 (-0.23%)
     
  • Bitcoin USD

    69,462.23
    +99.58 (+0.14%)
     
  • CMC Crypto 200

    1,439.42
    -7.25 (-0.50%)
     
  • FTSE 100

    8,228.07
    -17.30 (-0.21%)
     
  • Gold

    2,323.70
    -1.30 (-0.06%)
     
  • Crude Oil

    76.29
    +0.76 (+1.01%)
     
  • 10-Yr Bond

    4.4300
    0.0000 (0.00%)
     
  • Nikkei

    39,038.16
    +354.23 (+0.92%)
     
  • Hang Seng

    18,366.95
    -109.85 (-0.59%)
     
  • FTSE Bursa Malaysia

    1,614.37
    -3.49 (-0.22%)
     
  • Jakarta Composite Index

    6,921.55
    +23.60 (+0.34%)
     
  • PSE Index

    6,458.64
    -60.12 (-0.92%)
     

Raffles Medical CEO Loo acquires 100,000 shares at $1.03 each

After the purchase, Loo’s direct stake in Raffles Medical has increased to 11.573% from 11.568% previously.

Dr Loo Choon Yong, the CEO and a substantial shareholder of Raffles Medical Group BSL, has acquired 100,000 units in the company for $103,000 or $1.03 each.

The shares were sold via market transaction on March 19.

After the purchase, Loo’s direct stake in Raffles Medical has increased to 11.573% from 11.568% previously.

In addition, Loo has a deemed interest in another 783.8 million shares, giving him a total interest of 998.75 million shares, or 53.782%.

Units in Raffles Medical closed 1 cent higher or 0.97% up at $1.04 on March 20.

ADVERTISEMENT

See Also: